U.S. Vaccine Market, By Product Type (Human Vaccine, Animal Vaccine ), By End User - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Vaccines are biologically prepared products, which provide active acquired immunity to diseases such as cholera, polio, rotavirus, smallpox, yellow fever and others. A vaccine comprise an agent resembling to the disease causing microorganism. The vaccines are generally developed from live attenuated or killed forms of the disease causing microorganism, its toxins, or its surface proteins.

Restraints of the U.S. Vaccine Market

Major factors hampering the growth of the U.S. vaccine market during the forecast period constitutes of short functional shelf life of certain vaccines, and high costs.

Key features of the study:

• This report provides in-depth analysis of the U.S. vaccine market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the U.S. vaccine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The U.S. vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.

Detailed Segmentation

• U.S. Vaccine Market, By Product Type:
  • Human Vaccine
    • Pediatric Vaccines
    • Adult & Adolescent Vaccines
    • Other Human Vaccines
  • Animal Vaccine
    • Livestock Vaccines
    • Companion Animal Vaccines
    • Other Animal Vaccines
• U.S. Vaccine Market, By End User:
  • Hospitals
  • Clinics
  • Vaccination Centers
• Company Profiles
  • Sanofi Pasteur *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
  • GlaxoSmithKline Plc
  • Merck & Company Incorporated
  • Pfizer Incorporated
  • AstraZeneca plc
  • Boehringer Ingelheim

"*" marked represents similar segmentation in other categories in the respective section.